Nuveen Core Plus Bond ETF (NASDAQ:NCPB – Get Free Report) was the recipient of a significant decline in short interest in March. As of March 15th, there was short interest totalling 7,700 shares, a ...

Dividend Aristocrats in 2025 show resilience, outperforming the S&P 500. Click here to read what investors need to know.

Explore Q1 2025's biotech stock moves, from CervoMed's 300% surge to Septerna's struggles. Click for my review of the quarter ...

High Yield Stocks to Buy in April. In this article, we are going to take a look at where American Tower Corporation (NYSE:AMT ...

Investors looking to filter out the noise may want to consider stocks and exchange-traded funds (ETFs) that pay dividends. Scott Levine (Brookfield Infrastructure): Tumbling more than 8% since the ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Investors and traders might focus on the reasons behind periods of decline or higher volatility in the stock market. But long ...

The stocks on this list have all pulled back from loftier levels and could continue to pull back further, but there are ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

Vertex Pharmaceuticals (VRTX) is the second stock to buy for the Nasdaq 100 correction. The biotech stock offers stability ...

Casey’s General Stores (NASDAQ: CASY) insider Mike Spanos is buying shares. Mr. Spanos, COO at Delta Air Lines (NYSE: DAL) ...